SCHEMBL3324957

SCHEMBL3324957

CCCCCCCCCCC(CCCCCCCC)COC(=O)C(C)(C)CCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
PRSS1 P07477 2/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
TSHR P16473 3/20 0.41
CYP3A4 P08684 3/20 0.41
ATM Q13315 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ACACB O00763 1/20 0.41
ACACA Q13085 1/20 0.41
LMNA P02545 2/20 0.40
ELANE P08246 1/20 0.40
ZDHHC7 Q9NXF8 1/20 0.40
MAPT P10636 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA2 P00918 2/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16736958 1.00 CYP4F2 (0.50) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711151 0.94 ACACB (0.51) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711159 0.94 ACACB (0.51) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711161 0.93 CYP4F2 (0.44) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711153 0.93 CYP4F2 (0.44) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711406 0.89 ACACB (0.47) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711320 0.89 ACACB (0.47) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711393 0.89 ACACB (0.47) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711397 0.89 ACACB (0.47) CYP4F2CYP4A11PRSS1PRSS2PRSS3
SCHEMBL26711130 0.89 ACACB (0.47) CYP4F2CYP4A11PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249536-B1 ORGANOPOLYSILOXANE AND PRODUCTION METHOD THEREFOR, AND DISPERSION CONTAINING ORGANOPOLYSILOXANE AS DISPERSANT JNC CORP (JP) 2025-09-03 EP disclosed
WO-2024202411-A1 OIL-BASED SOLID CLEANSING COSMETIC 岩瀬コスファ株式会社 2024-10-03 WO disclosed
CN-118215456-A Composition for hair and/or skin, method for treating hair and/or skin, and device for hair and/or skin 株式会社玫丽盼 2024-06-18 CN disclosed
CN-117940109-A Composition for preventing bromhidrosis 持田制药株式会社 2024-04-26 CN disclosed
US-20230399469-A1 ORGANOPOLYSILOXANE AND PRODUCTION METHOD THEREFOR, DISPERSANT COMPRISING ORGANOPOLYSILOXANE, AND DISPERSION CONTAINING ORGANOPOLYSILOXANE AS DISPERSANT JNC CORPORATION (JP) 2023-12-14 US disclosed
EP-4249536-A1 ORGANOPOLYSILOXANE AND PRODUCTION METHOD THEREFOR, AND DISPERSION CONTAINING ORGANOPOLYSILOXANE AS DISPERSANT JNC Corporation (JP) 2023-09-27 EP disclosed
CN-116568759-A Organopolysiloxane, method for producing same, and dispersion liquid containing organopolysiloxane as dispersant 捷恩智株式会社 2023-08-08 CN disclosed
WO-2023145306-A1 HAIR AND/OR SKIN COMPOSITION, METHOD FOR TREATING HAIR AND/OR SKIN, AND DEVICE FOR HAIR AND/OR SKIN 株式会社ミルボン 2023-08-03 WO disclosed
WO-2023112664-A1 PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION WHICH CONTAINS BENZOYL PEROXIDE ロート製薬株式会社 2023-06-22 WO disclosed
WO-2023042911-A1 ANTI-ARMPIT-ODOR COMPOSITION 持田製薬株式会社 2023-03-23 WO disclosed
EP-2092931-B1 Oil-in-water emulsified milky skin cosmetic preparation SHISEIDO CO LTD (JP) 2012-08-15 EP disclosed
US-8182828-B2 Oil-in-water emulsified milky skin cosmetic preparation SHISEIDO COMPANY LTD. (JP) 2012-05-22 US disclosed
US-20100119470-A1 Method Of Reducing The Appearance Of Wrinkles SHISEIDO COMPANY, LTD. (JP) 2010-05-13 US disclosed
EP-2092931-A1 Oil-in-water emulsified milky skin cosmetic preparation Shiseido Co., Ltd. (JP) 2009-08-26 EP disclosed
US-20090202600-A1 Oil-In-Water Emulsified Milky Skin Cosmetic Preparation SHISEIDO COMPANY LTD. (JP) 2009-08-13 US disclosed
US-20070148120-A1 Skin preparations for external use for wrinkle reduction SHISEIDO COMPANY LTD. (JP) 2007-06-28 US disclosed
EP-1704849-A1 SKIN PREPARATIONS FOR EXTERNAL USE FOR WRINKLE DIMINUTION SHISEIDO COMPANY, LTD. (JP) 2006-09-27 EP disclosed
US-6955491-B2 Marking pen with excellent cap-off performance MITSUBISHI PENCIL KABUSHIKI KAISHA (JP) 2005-10-18 US disclosed
US-20040067093-A1 Marking pen with excellent cap-off performance MITSUBISHI PENCIL KABUSHIKI KAISHA (JP) 2004-04-08 US disclosed
EP-1346849-A1 MARKING PEN WITH EXCELLENT CAP-OFF PERFORMANCE Mitsubishi Pencil Kabushiki Kaisha (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090202600-A1 Oil-In-Water Emulsified Milky Skin Cosmetic Preparation CUTA, ACMSD, MC1R CYP4F2 4476/4885CYP4A11 2759/4885PRSS1 2736/4885
US-20070148120-A1 Skin preparations for external use for wrinkle reduction CUTA, MMS19, COL14A1 CYP4F2 3965/4885CYP4A11 4018/4885PRSS1 3905/4885
US-20100119470-A1 Method Of Reducing The Appearance Of Wrinkles CUTA, MMS19, COL14A1 CYP4F2 4400/4885CYP4A11 4481/4885PRSS1 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.